Drug intelligence / Profile preview

健都牌密骨胶囊

Development stage: Unknown
Lead developer: Beijing Jiandu Pharmaceutical
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Oral

Overview

健都牌密骨胶囊是一种中国保健食品，主要用于中老年人群以增加骨密度、辅助防治原发性骨质疏松症。其配方基于“肾主骨”理论，结合现代营养学和中医药成分，包括鸡蛋壳（提供天然钙）、大豆异黄酮（植物雌激素）、淫羊藿（传统补肾壮阳药材）及维生素D。动物实验和临床研究显示，该产品可有效维持腰椎及髋部的骨矿密度，对缓解因原发性骨质疏松导致的腰背疼痛有一定作用[3][6][7]。本品为口服制剂，每粒0.5g，建议每日2次，每次2粒[3]。

Brand names: 健都牌密骨胶囊
Other names: 密骨胶囊

Targets

ESR2 (ERβ)VDR (Vitamin D receptor)ESR1 (ERα)

Beyond the preview

Go deeper on 健都牌密骨胶囊.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 健都牌密骨胶囊.

Explore the full profile